Indegene Limited (NSE:INDGN)

Market Cap	138.19B
Revenue (ttm)	27.57B
Net Income (ttm)	3.84B
Shares Out	239.27M
EPS (ttm)	16.34
PE Ratio	35.35
Forward PE	29.46
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,913,065
Average Volume	758,462
Open	567.90
Previous Close	577.55
Day's Range	519.40 - 568.95
52-Week Range	470.10 - 736.30
Beta	n/a
RSI	54.36
Earnings Date	May 29, 2025

About Indegene

Indegene Limited operates as a life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, and Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technology platfor...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1998
• Employees: 4,367
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: INDGN

Financial Performance

In 2023, Indegene's revenue was 25.90 billion, an increase of 12.29% compared to the previous year's 23.06 billion. Earnings were 3.37 billion, an increase of 26.53%.